Imugene Ltd
IMU•Health Care•Biotechnology•Last updated: Dec 25
About
Imugene Ltd is a clinical-stage immuno-oncology company. The Company is focused on developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors. Its pipeline includes multiple B-cell peptide vaccines and oncolytic virotherapy candidates targeting a variety of cancers.
Share Price Chart
Company Details
- Sector
- Health Care
- Industry
- Biotechnology
- ASX Code
- IMU
Related Shares
Investor Resources
Should you buy Imugene Ltd right now?
While IMU looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.
Join the Rask weekly investment newsletter to get the names, right now